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Abstract. In this paper we present a portable magnetocardiography device. The
focus of this development was delivering a rapid assessment of chest pain in an
emergency department. The aim was therefore to produce an inexpensive device
that could be rapidly deployed in a noisy unshielded ward environment. We
found that induction coil magnetometers with a coil design optimized for magnetic
field mapping possess sufficient sensitivity (104fT/
√
Hz noise floor at 10Hz) and
response (813fT/µV at 10Hz) for cycle averaged magnetocardiography and are able
to measure depolarisation signals in an unshielded environment. We were unable to
observe repolarisation signals to a reasonable fidelity. We present the design of the
induction coil sensor array and signal processing routine along with data demonstrating
performance in a hospital environment.
PACS numbers: 06.30.Ka, 41.20, 87.19, 87.57.-s
1. Introduction
Chest pain is responsible for one of the highest rates of emergency hospital visits in
industrialized countries [1] and accounts for a large proportion of hospital admissions.
Statistics show that around 75% of patients who present at the Emergency Department
with chest pain do not have a cardiac related condition [2–5], yet they still need to go
through a full diagnostic pathway which can take more than 10 hours [2]. This leads to
several thousand people occupying bed spaces placing an additional burden on health
care systems. A diagnostic that is capable of rapidly stratifying the cases and removing
those patients who don’t need an overnight stay is therefore valuable in both triage and
cost saving [2].
Magnetocardiography (MCG) involves capturing Magnetic Field Maps (MFM’s) of
current distributions resulting from cardiac action potentials [6–14]. It has been shown
that MCG gives significant improvements in diagnostic capability over an ECG [15–26].
Significantly, in this respect, it has been demonstrated that MCG is capable of reliable
detection of Non-ST-Elevated Myocardial Infarction (NSTEMI) [15, 22], which are
by definition difficult to detect using ECG. For this reason all ECG negative chest
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pain patients are treated as having an NSTEMI until other diagnostic results can
be obtained [3]. Hence, the short time to produce a MCG (typically <10 minute
measurement) dramatically reduces the time for diagnosis and removes otherwise healthy
patients earlier in the process and is therefore a tool with obvious clinical benefits.
The principle focus of the current research was the creation of a portable MCG
device that would be capable of providing a rapid assessment of acute coronary syndrome
(ACS) in an Emergency Department. To meet this goal, the device requirements are
sensitivity to a magnetic window of between 0.1pT and 300pT, in the frequency range
of around 1–40 Hz [27] and a spatial resolution sufficient to detect anomalies with a
spacing of 10–15cm (for a sensor operated 10cm from the chest wall) [28].
Cardiac MFM devices typically use an array of sensitive magnetometers detectors
to collect the magnetic field of the heart by simultaneously sampling at many positions
across the chest. Sensors include liquid helium cooled SQUID detectors, which have
been used in commercially available devices for over 40 years [29], and atomic physics
detectors and giant magnetoresistance detectors have also been developed [27,30,31].
These devices are not always suitable for an Emergency Department as the
associated apparatus is bulky, they often require liquid helium, specialist training
to use, they are fixed in place and typically require an electromagnetically shielded
room. In contrast, induction coil magnetometers have been used several times for
cardiac magnetic field detection by several authors. They meet the demands of
signal sensitivity [32–37], they are inexpensive, do not require cooling and can be run
from batteries. However earlier efforts required noisy high gain amplifiers, large and
heavy coils which are unsuitable for magnetic field mapping and fixed electronically
implemented gradiometer arrangements. Here we present a more compact coil design
which when combined with modern analog-to-digital converters (ADC’s) and digital
signal processing (DSP) produces a device capable of detecting the cardiac magnetic
field with an array of 19 sensors.
We first present the design of the sensors, array and DSP routine. Then we show
that this design has the capability of resolving the field of the heart within both shielded
and unshielded environments.
2. Apparatus
2.1. Coil Design
The most important aspect of this device is the construction of the sensor elements
to achieve both the sensitivity and required spatial resolution. An induction coil
magnetometer will have an output voltage determined by
V = AN
dB(t)
dt
= ANB2pif (1)
where N is the number of windings, A is the effective cross sectional area of the coil,
B(t) is the time varying magnetic field, with a magnitude B, and f is the frequency
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of oscillation of the field. The smallest field, S, that can be detected given thermal
Johnson noise resulting from the winding resistance is given by: detected given thermal
Johnson noise resulting from the winding resistance is given by:
S =
√
4kBTRa
2pifNA
(2)
where kB is Boltzmans constant, T is the temperature, Ra is the antenna wire
resistance given by:
Ra = N2pi
2a2ρrcoil (3)
where a is the radius and ρ is the resistivity of the wire used in the windings on a
circular coil of average winding radius rcoil. Equations 1, 2 can be used to find the coil
structure with lowest noise level given the design constraints.
If the coil parameters are the length L, the coil outer diameter, D, and the coil
inner diameter, Di, the dimensions that give the lowest noise level have the ratio
Di : D = 0.425 : 1. In addition to this we primarily want to measure the component of
the magnetic field aligned to the axis of the coil. Zilstra [38] notes that the optimum
coil structure to measure the axial component of the magnetic field is achieved when
L/D = 0.69 for the above ratio Di/D. The coil diameter itself is determined according
to the desired device resolution, leaving the radius of the wire only remaining free
parameter in the coil design.
The output voltage of the coil is determined by N. As all other parameters are now
fixed, voltage is determined exclusively by the wire radius a. A thinner wire increases
the voltage output at the expense of increased coil resistance and subsequently increased
noise, leading to a fixed signal to noise ratio irrespective of wire diameter.
Table 1 presents outputs from a simulation of the coil design presented here
(MFM Coil) compared to the Brooks coil of the same outside dimension and wire
diameter, a = 0.23mm. A Brooks coil is a special case in which the ratio of the
dimensions are chosen to optimise inductance for which the ratio of the dimensions are
D : Di : L = 4 : 2 : 1. The current MFM Coil design has a higher voltage and a lower
noise equivalent field at the target frequency of 30Hz than the Brooks coil. The noise
equivalent field is the smallest field strength that could be measured above Johnson
noise of the detector. The gains are a factor of 1.6 in signal to noise and a factor of
about 2.9 in output voltage.
The increased signal size plays a role in the subsequent electronics especially when
thermal and Johnson noise in the electronics is similar in size to the cardiac signal.
Overall both effects improve data collection times by a factor of 20. This is important
because, while the gains are modest, the overall impact on the design is a significant
reduction (more than an order of magnitude) in the data collection time when cycle
averaging is used.
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Table 1. Table comparing the classic Brooks coil design with the MFM coil design
presented in this paper.
Coil D Di L Vout at 1pT (40Hz) Noise Equivalent Field
MFM 12cm 5.1cm 8.28cm 616nV 57fT
Brooks 12cm 6cm 3cm 211nV 96fT
MFM 8.5cm 3.6cm 5.87cm 155nV 136fT
Brooks 8.5cm 4.25cm 2.125cm 53nV 227fT
MFM 4.25cm 1.8cm 2.9cm 9.5nV 773fT
Brooks 4.25cm 2.125cm 1.0625cm 3.3nV 1.3pT
2.2. Mapping Array Construction
The commercial analog to digital converter (ADC) we used has 16 channels. One channel
was reserved for the ECG trigger, leaving 15 cardiac magnetometer channels. MFMCoils
with a diameter of 7cm were chosen to cover the measurement area of ∼ 25× 25cm in
a hexagonal array, arranged in order to detect the principle components of the hearts
magnetic dipole field.
To evaluate the mapping fidelity of this arrangement a COMSOL model of the
array was created. The interaction of the soft iron cores with a static magnetic dipole
field comparable in size to the cardiac dipole was simulated. Measurements of the flux
at the coil centers were taken as readings equivalent to sensor output. These outputs
were spatially interpolated using the same technique as used with actual sensor signals
to produce MFM. From the MFM the field map angle (FMA) was measured from the
vector between the dipole maxima. Figure 2 shows the actual and measured MFM’s
at a fixed angle. The simulated cardiac dipole was rotated in small increments. At
each increment the difference between the actual angle and the measured angle was
calculated. The maximum difference observed was 15o, with a typical error of 8o. This
uncertainty can be reduced by taking the vector between pole centroids, this spatially
averaged measurement of the dipole vector has a considerably lower uncertainty of < 1o.
To collect cardiac magnetic fields we designed a mount to hold up to 19 coils with
a hexagonal close packed layout of sensor locations, see Figure 4. The layout, the
approximate location against the body and a system level diagram for data acquisition
are shown in figure 3. Since movement of the coils within the Earth’s field will induce
a current in the coils, they must be stiﬄy coupled so that acoustically induced signals
become common mode and therefore removable by gradiometry. To this end, the mount
was manufactured from a single piece of Acetal engineering plastic and the coils were
securely potted in place. It was supported above the suppine participant by a four legged
aluminium frame coupled to the floor. The large mass provided inertial dampening.
2.3. Data Acquisition and DSP
To extract signal from the coils with minimum interference a low noise pre-amplifier
(3.5nV/
√
Hz at 10Hz) with a gain of 1000× was placed immediately above each MFM
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Coil, see Figure 5 for details. The signal was then digitized using a National Instruments
16-channel 2kS/s 24bit AC-coupled ADC with a rail-rail voltage of 316mV (37nV
sensitivity). Cycle averaging, filtering and gradiometry were performed in digital post
processing [?].
Cycle averaging used the ECG R-wave rising edge as a fiducial. The magnetometer
signals were sliced in an interval of ±500ms about the fiducial, these intervals were then
averaged. A moving average filter was applied by convolution of the signal with a 20ms
wide top hat distribution [39].
In the normal mode of operation of a magnetic gradiometer it is considered
necessary to have extensive shielding or closely matched gradiometer coils. But matching
wire wound induction coils to sufficient accuracy is effectively impossible. However, in an
array of coils differences in coil sensitivity are reduced by taking the average, and since
the spatial average over a dipole crossection is zero, the cardiac signal is not present in
this background. Hence, this background is a bucket detector. Subtracting the bucket
detector signal from a sensor signal produces a gradiometric signal.
Induction coils measure the time derivative of the magnetic field and not the
static field. It is not possible to accurately construct the static field components by
integrating their signals since the constant of integration is unknown. Attempting to
numerically integrate yeilds signals with large baseline wander. This makes induction
coil magnetometers not ideal for low frequency field measurement, though their
performance can be improved with a fluxgate arrangement [40] or mechanical dithering
of the sensors [41]. The derivative signals do not contain reliable absolute amplitude
information, but they contain the same relative amplitude information and therefore the
normalised spatial measurement is unaffected. Therefore the majority of the diagnostic
information is preserved.
3. Results And Discussion
3.1. Sensor Response and Sensitivity
The sensor response was measured by placing one in the center of a helmholtz coil
pair, applying a calibrated sinusoidal field and measuring the sensor output amplitude,
as shown in Figure 6. The applied magnetic field amplitude was measured using a
calibrated fluxgate magnetometer. The response is dependent on the field frequency
and for this coil, it is linear between 1Hz and 1KHz. The measured response was
290fT/µV at 30Hz and 813fT/µV at 10Hz.
The sensitivity is determined by the inherent sensor noise. To measure the inherent
noise the sensor was placed in a shielded room and 10 minutes of signal were recorded.
Computing a FFT on this timeseries gives the amplitude spectral density of the sensor,
see Figure 7. This voltage amplitude spectra was converted into magnetic field amplitude
by factoring in the coils frequency response. The resulting noise floor was 104fT/
√
Hz
at 10Hz and 36fT/
√
Hz at 30Hz.
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3.2. First MCG Measurements
Now we show that these coils can detect the magnetic field with sufficient sensitivity and
sufficiently low inherent noise. An MCG was taken in a shielded environment, where the
environmental noise was low enough to observe dominant sensor noise. Figure 8d shows a
raw MCG sensor signal taken from one of us in a shielded room which had an attenuation
of 40dB at 1Hz and a maximum attenuation of 104dB at 30Hz. Aproximately 10 minutes
of data were recorded containing 485 cardiac cycles over 12 coils. The noise amplitude
was approximately 0.6mV RMS (< 73pT ).
The synchronously recorded 3 lead ECG shown in Figure 8b was thresholded to find
the R-wave rising edge, this was used as a fiducial for cycle averaging, which reduced
the noise amplitude by a factor of 35 (to < 2.1pT ). Then the gradient was calculated
by subtracting the synthetic bucket detector. However, this did not reduce the noise
amplitude since it was composed of Johnson thermal noise which is uncorrelated across
the array. Finally a 20ms wide moving average filter was applied to notch out the
remaining 50Hz noise and smooth the remaining thermal noise.
The resulting signal has no significant noise (< 150fT ) and corresponds with the
anti-derivative of previously observed MCG signals [42,43]. It has a maximum amplitude
during cardiac depolarisation of 0.05mV (30pT ).
To analyse the device performance in an unshielded enironment an MCG was
recorded at Leeds General Infirmary, the results are shown alongside the shielded data
in Figure 8. Similarly 10 minutes of data were recorded, yeilding 482 cardiac cycles.
The noise amplitude is much larger compared to the shielded room signals at 80mV
(∼ 20nT ), and highly correlated across the array. Cycle averaging reduces this by a
factor of 12. Application of synthetic gradiometry provides 10× rejection. The same
20ms wide moving average filter is highly effective at removing the remaining 50Hz
noise and it’s harmonics leading to 500× supression. The resulting signal is the same
amplitude as acquired in the shielded room, however there is a large coloured noise
content.
This coloured noise could be removed by the aplication of more advanced DSP
techniques such as wavelet denoising [44], reference data based non-linear denoising
as an alternative improvement to gradiometry [45], and EEMD for baseline wander
removal [46]. A second layer of coils ontop could provide an improvement to gradiometer
performance as the second coils would be coaxial with the first but receive reduced
cardiac magnetic flux [47].
The sensitivity to low frequency could be increased by lock-in to a global excitation
field provided by a fluxgate or mechanical dithering arrangement [40, 41,48–50].
MFM’s represent the magnetic field at a chosen instant in the cardiac cycle. They
are created by spatially interpolating the sensor amplitudes from a common time sample.
Figure 9 compares the shielded and unshielded MFM’s at -15ms, during the magnetic
R wave peak activity.
The dipole angle is consistent between the two MFM’s. The dipole position is
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translated between the MFM’s since the array was only subjectively aligned in the
coronal plane relative to the Xiphoid process. Also the angle between the coronal and
transversal planes was not precisely controlled, since each bed had a different distribution
of padding material. Ideally the MFM would be precisely referenced to the individuals
cardiac geometry. This would be invaluable for solving the inverse problem; estimating
the structure of the underlying current distribution corresponding to the observed MFM.
The observed dipole angle and size are in good agreement with past MCG
observations of healthy normals [22]. We therefore anticipate that the signal has similar
diagnostic value.
4. Conclusion
We have presented a new design for a device to perform magnetic field mapping and
demonstrated that the device collects useful magnetocardiography data in shielded and
unshielded environments.
The shielded measurements prove that the coil sensor system has sufficiently low
inherent noise for cycle averaged MCG and sufficient spatial resolution for field map
angle measurement.
However, operation of the device within an unshielded environment imposes
coloured noise on the signal of an amplitude comparable to the repolarisation signals
(ECG T wave). This potentially limits the diagnostic capability of our device
within unshielded environments. Though the depolarisation signals (QRS) are reliably
observable above this noise. This result may be improved by the application of recent
developments in denoising algorithms [44–46].
Further clinical testing will be required to determine if it is capable of detecting
recent onset of NSTEMI in patients with the same accuracy as previous devices. A
future device may want to use more sensors to increase the measurement area and may
also consider smaller coils to achieve a higher resolution. The addition of a second layer
of coils would provide a vertical baseline for synthetic gradiometry which may improve
environmental noise suppression [47]. The low frequency performance could be improved
to reach DC by lock-in to a global excitation field [40,41,48–50].
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Figure 1. Photograph of the 7cm diameter coil sensors used. The 2cm diameter core
is visible in the centre of the coil bobbin. The pre-amplifier circuit board is mounted to
the coil to minimise the unshielded signal path. DC battery power is provided via the
4-way header. The amplified signals are output via an SMB connector into a coaxial
cable.
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Figure 2. COMSOL model of the sensor array measuring an ideal cardiac dipole field.
Figure a shows the cardiac dipole field, which is sampled at the center of the soft iron
cores shown as black spots. Figure b shows the interpolated measurement of the field
samples. The actual angle and the reconstructed rotation angle are closely matched
indicating that an accurate reconstruction is possible with this sensor array.
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Figure 3. System level diagram; Individual pre-amplified sensor signals are acquired
by the ADC, then processed within a computer to create a magnetocardiogram.
Figure 4. Photograph of the sensor array. The array was machined out of Acetyl
engineering plastic, which stiﬄy couples the sensors together. This array was then
bolted to an aluminium frame which supported it above a supine participant in order
to capture MCG.
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Figure 5. Schematic of a single sensor channel. The DC offset control loop is used to
remove drift generated by the amplifier, it functions as a high pass filter with a cut-off
of 1.6Hz. The amplifier power supply (V+, V-) is supplied by a pair of batteries with
local fixed LDO voltage regulators.
Figure 6. Experiment to measure sensor response. A sinusoidal field was created
by the helmholtz coils being driven by the signal generator, the peak field amplitude
was measured using a calibrated fluxgate magnetometer. The fluxgate probe was then
replaced by a MFM coil sensor and the peak amplitude output by the sensor as recorded
using the oscilloscope.
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Figure 7. Amplitude spectral density of the sensor in shielded (YNIC) and unshielded
(LGI) environments, computed by FFT. The sensor voltage spectral density was
computed then the frequency dependent response was used to convert to units of
magnetic field amplitude (fT).
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Figure 8. Comparison of two magnetometer signals from the same person taken with
an identical device, with similarly positioned sensors but in different environments.
The Sheilded MCG was acquired in the York Neuroimaging center (YNIC). The
Unsheilded MCG was acquired at Leeds General Infirmary (LGI), 16 months later.
The environmental noise is 100× larger in LGI. Averaging reduces the noise amplitude
by 20×. Gradiometry (subtracting the synthetic bucket detector signal) provides 10×
noise reduction at LGI but does not effect the noise amplitude at YNIC, in this case
it reduces the signal amplitude as the dipole measurement was not symmetric. A final
stage FIR filter notches out 50Hz, reducing LGI noise by 500× and acting mostly as
a smoothing filter in LGI with 20× reduction. The final signal amplitudes differ by
40% which could be explained by a difference in sensor positioning or physiological
differences. The unshielded signal has a similar level of white noise, but a much larger
coloured noise component.
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Figure 9. MFM’s of the author, during the rising edge of the ECG r-wave. MFM on
the left was taken in the YNIC shielded room. The MFM on the right was taken in
an unshielded room at Leeds General Infirmary. The shielded measurement used 12
coils as the pre-amplifier wiring broke on three of the coils during transportation of
the device to YNIC.
